Tom Dodd
Ask VT AI
View News Summary
- Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on the back of its HIV portfolio and new drug launches.
- Israel plans to occupy Gaza City, disarm Hamas, and transfer control to Arab forces, despite concerns over humanitarian risks and hostage lives.
- Restaurant Brands' Q2 profit falls, but revenue beats estimates as international growth offsets domestic challenges.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on the back of its HIV portfolio and new drug launches.
- Israel plans to occupy Gaza City, disarm Hamas, and transfer control to Arab forces, despite concerns over humanitarian risks and hostage lives.
- Restaurant Brands' Q2 profit falls, but revenue beats estimates as international growth offsets domestic challenges.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Tom Dodd
News from Tom Dodd